Navigation Links
Paramount Completes Acquisition of Chem Rx
Date:10/26/2007

NEW YORK, Oct. 26 /PRNewswire-FirstCall/ -- Paramount Acquisition Corp. (OTC Bulletin Board: PMQC, PMQCU, PMQCW) ("Paramount") announced today it has completed the acquisition of 100% of the outstanding stock of B.J.K. Inc., a New York corporation doing business as Chem Rx ("Chem Rx"), pursuant to a Stock Purchase Agreement, by and among Paramount, Chem Rx and the shareholders of Chem Rx, dated June 1, 2007, as amended. Effective as of the closing of the acquisition, Paramount has changed its name to "Chem Rx Corporation."

ABOUT CHEM RX

Founded more than 40 years ago, Chem Rx is a major, privately-owned long- term care pharmacy serving the New York City metropolitan area, as well as parts of New Jersey, upstate New York, and Pennsylvania. Chem Rx's client base includes skilled nursing facilities and a wide range of other long-term care facilities. Chem Rx provides to more than 61,000 residents prescription and non-prescription drugs, intravenous medications, durable medical equipment items and surgical supplies. Chem Rx's website address is http://www.chemrx.net.

ABOUT PARAMOUNT ACQUISITION CORP.

Paramount Acquisition Corp. was formed for the specific purpose of effecting a merger, capital stock exchange, asset acquisition, or other similar business combination with an operating business in the healthcare industry. Paramount raised net proceeds of approximately $53 million through its initial public offering consummated in October 2005 and exercise of the over-allotment option, and has dedicated its attention since the offering to seeking and evaluating business combination opportunities.

Cautionary Statements

This press release contains forward-looking statements about Paramount, Chem Rx and their combined business after completion of the proposed business combination. Forward-looking statements are statements that are not historical facts. Such forward-looking statements a
'/>"/>

SOURCE Paramount Acquisition Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. iGATE Completes Phase I Testing Of Meningitis Vaccine
2. Delhi Hospital Completes 100 Liver Transplants
3. Roche Completes Acquisition of BioVeris
4. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
5. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
6. NHS financial crisis may lead to roll back of flexi-work scheme and private acquisition
7. Smoking Increases Risk of HIV Acquisition
8. Circassia Announces Acquisition of Organ Transplant Anti-Rejection Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... (PRWEB) November 27, 2014 In order to ... from Sharpes, Fla., designed an easy way to avoid touching ... , He then created a prototype of the patent-pending Toilet ... lower a toilet seat and/or lid in a more sanitary ... the spread of germs. Overall, it promotes good hygiene and ...
(Date:11/27/2014)... November 27, 2014 The founders of VIM ... comfortable and high functioning compression socks, are proud to announce ... use an innovative Gradient Pressure (TM) knitting technology that is ... VIM & VIGR’s commitment to adding flair and style to ... functional recently caught the eye of a writer at ...
(Date:11/27/2014)... Jeffrey Carlini has practiced public ... area providing audits, reviews, compilations, tax preparation, business ... varying size across numerous industries. Jeff has worked ... of their accounting and tax needs. , Jeff ... Program. When asking Mr. Carlini about his recent ...
(Date:11/27/2014)... Vegas, NV (PRWEB) November 27, 2014 ... 2014 shopping season has officially launched, Emassagechair.com ... and Cyber Monday Discount Event. , Negotiating on ... relationships with top massage chair brands, Emassagechair.com has generated ... their best deals and biggest discounts yet. , Shoppers ...
(Date:11/27/2014)... York, New York (PRWEB) November 27, 2014 ... of individuals who were allegedly injured by the medication ... where a federal litigation is looking ahead to a ... , According to a Scheduling Order issued earlier this ... place on December 16th at 10:00 a.m. Items likely ...
Breaking Medicine News(10 mins):Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:Jeffrey Carlini becomes Intuit Proadvisor and receives QuickBooks certification 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 2Health News:Federal Litigation Presiding over Tylenol Lawsuits Looks Ahead to Status Conference in December, Bernstein Liebhard LLP Reports 3
... type 1 a rare disease in which tumors grow ... by crosstalk between cells in the nerves and cells in ... National Institutes of Health (NIH) and the Department of Defense ... treating certain kinds of blood cancer curbs tumor growth in ...
... One errant cough or unexpected,sneeze and the workplace ... As the flu season approaches, HR managers prepare to,deal ... estimates that the cost of influenza to the U.S. ... can range from $71 billion,to $167 billion a year., ...
... Living,Inc. (NYSE: SRZ ) today announced that it ... 7, 2008, at 9:00 a.m. ET to discuss the,financial ... executive,officer (effective November 1, 2008), Richard Nadeau, chief financial,officer, ... call., The call-in number for the conference call ...
... Institute of Health and Nutrition, Latino Nutrition Coalition are ... ... Inc. (GMI), today,announced the launch of a unique, three-year, grassroots program ... nutritious food as part of their daily routine. Called Mente,Sana en ...
... Action Network, American,Heart Association, American Lung Association, American ... Oct. 30 Demonstrating again that,it is not ... Philip Morris,is launching an aggressive new campaign to ... campaign is built around a new look for ...
... LLC formally launched a,refreshed website ( ... and,potential customers on October 28, 2008. The ... target-market, including temporary,nurse staffing agencies, medical transcription ... healthcare vendors., Some of the site,s ...
Cached Medicine News:Health News:Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis 2Health News:Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosis 3Health News:Going 'Green' May Mean Fewer Colds This Season 2Health News:Going 'Green' May Mean Fewer Colds This Season 3Health News:Sunrise to Host Conference Call and Webcast to Discuss the Company's Financial Results for the Third Quarter 2008 2Health News:General Mills, Inc. Launches One-Of-A-Kind Grassroots Health and Nutrition Initiative Designed to Help Hispanic Families Eat Better 2Health News:General Mills, Inc. Launches One-Of-A-Kind Grassroots Health and Nutrition Initiative Designed to Help Hispanic Families Eat Better 3Health News:Deadly in Pink: Philip Morris' New Look for Virginia Slims Cigarettes Shows Contempt for Women's Health 2Health News:Deadly in Pink: Philip Morris' New Look for Virginia Slims Cigarettes Shows Contempt for Women's Health 3Health News:PRN Funding Refreshes Website Experience 2
(Date:11/27/2014)... -- - New Solution That Makes JINS ... JIN Co., Ltd. will launch JINS MEME "ACADEMIC PACK" in ... or $5,000 (without tax /including two pairs of JINS MEME ... dedicated solution of "JINS MEME" to academic researchers, and it ... by electrooculography and six-axis sensors without API. (*Physiological data that ...
(Date:11/26/2014)... 26, 2014  Thoratec Corporation (NASDAQ: THOR ... therapies to save, support and restore failing hearts, said ... conferences. On Tuesday, December 2, the company ... Jaffray Healthcare Conference.  D. Keith Grossman , President ... the company beginning at 11:30 a.m., Eastern Standard Time ...
(Date:11/26/2014)...   Royal Philips (NYSE: ... of its portfolio of diagnostic X-ray solutions ... , ProGrade and PrimaryDiagnost[ii]. With new releases of ... U.S., and availability of all these solutions in ... innovative solutions designed to meet the needs and ...
Breaking Medicine Technology:JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Thoratec Announces Presentations At Investor Conferences For December 2014 2Philips expands global reach of diagnostic X-Ray solutions 2Philips expands global reach of diagnostic X-Ray solutions 3
... findings of the first cost-effectiveness analysis of Vimpat® ... partial-onset seizures.  The findings were presented at the ... (ISPOR) annual meeting in Baltimore, MD, USA.   ... to analyze standard anti-epileptic drug therapy with and ...
... Pa., May 31, 2011 CSL Behring ... Designations (ODD) by the European Commission for the development of ... (rVIIa-FP), a novel therapy to treat hemophilia A and hemophilia ... to exclusively market recombinant factor VIIa fused with albumin in ...
Cached Medicine Technology:New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 2New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 3New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 4New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 5New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 6New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 7New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V 8CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment 2CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment 3CSL Behring Receives EU Orphan Drug Designations for rVIIa-FP for Hemophilia A and B Treatment 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: